SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006114
Filing Date
2017-08-07
Accepted
2017-08-07 16:07:15
Documents
66
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q depo-20170630x10q.htm 10-Q 2307615
2 EX-10.2 depo-20170630ex1021c6d65.htm EX-10.2 65404
3 EX-31.1 depo-20170630ex31161c186.htm EX-31.1 20315
4 EX-31.2 depo-20170630ex312f3a163.htm EX-31.2 20998
5 EX-32.1 depo-20170630ex32174a25a.htm EX-32.1 9123
6 EX-32.2 depo-20170630ex3221304ec.htm EX-32.2 9635
  Complete submission text file 0001558370-17-006114.txt   8460175

Data Files

Seq Description Document Type Size
7 EX-101.INS depo-20170630.xml EX-101.INS 1859355
8 EX-101.SCH depo-20170630.xsd EX-101.SCH 49162
9 EX-101.CAL depo-20170630_cal.xml EX-101.CAL 75668
10 EX-101.DEF depo-20170630_def.xml EX-101.DEF 214756
11 EX-101.LAB depo-20170630_lab.xml EX-101.LAB 494625
12 EX-101.PRE depo-20170630_pre.xml EX-101.PRE 345938
Mailing Address 7999 GATEWAY BLVD. SUITE 300 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD. SUITE 300 NEWARK CA 94560 510-744-8000
DEPOMED INC (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13111 | Film No.: 171011552
SIC: 2834 Pharmaceutical Preparations